Global Market Direct’s pharmaceuticals report, “ERYtech Pharma - Product Pipeline Review - 2013” provides data on the ERYtech Pharma’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ERYtech Pharma’s corporate website, SEC filings, investor presentations and featured press releases, both from ERYtech Pharma and industry-specific third party sources, put together by Global Markets Direct’s team.
- ERYtech Pharma - Brief ERYtech Pharma overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of ERYtech Pharma human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. - Product profiles for late stage and clinical stage products of ERYtech Pharma with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the ERYtech Pharma’s pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products.
Reasons to buy
- Evaluate ERYtech Pharma’s strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of ERYtech Pharma in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the ERYtech Pharma’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. - Exploit collaboration and partnership opportunities with ERYtech Pharma. - Avoid Intellectual Property Rights related issues. - Explore the dormant and discontinued projects of ERYtech Pharma and identify potential opportunities in those areas.
Table Of Contents
ERYtech Pharma - Product Pipeline Review - 2013 Table of Contents 2 List of Tables 3 List of Figures 3 ERYtech Pharma Snapshot 4 ERYtech Pharma Overview 4 Key Information 4 Key Facts 4 ERYtech Pharma - Research and Development Overview 5 Key Therapeutic Areas 5 ERYtech Pharma - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 ERYtech Pharma - Pipeline Products Glance 9 ERYtech Pharma - Late Stage Pipeline 9 Phase III Products/Combination Treatment Modalities 9 ERYtech Pharma Clinical Stage Pipeline Products 10 Phase II Products/Combination Treatment Modalities 10 Phase I Products/Combination Treatment Modalities 11 ERYtech Pharma - Early Stage Pipeline Products 12 Pre-Clinical Products/Combination Treatment Modalities 12 ERYtech Pharma - Drug Profiles 13 asparaginase 13 Product Description 13 Mechanism of Action 13 RandD Progress 13 Enhoxy 15 Product Description 15 Mechanism of Action 15 RandD Progress 15 ERYGEN 16 Product Description 16 Mechanism of Action 16 RandD Progress 16 ERYtech Pharma - Pipeline Analysis 17 ERYtech Pharma - Pipeline Products by Therapeutic Class 17 ERYtech Pharma - Pipeline Products by Route of Administration 18 ERYtech Pharma - Pipeline Products By Mechanism of Action 19 ERYtech Pharma - Recent Pipeline Updates 20 ERYtech Pharma - Dormant Projects 22 ERYtech Pharma - Locations And Subsidiaries 23 Head Office 23 Other Locations and Subsidiaries 23 Appendix 24 Methodology 24 Coverage 24 Secondary Research 24 Primary Research 24 Expert Panel Validation 24 Contact Us 25 Disclaimer 25
List of Tables
ERYtech Pharma, Key Information 4 ERYtech Pharma, Key Facts 4 ERYtech Pharma - Pipeline by Indication, 2013 6 ERYtech Pharma - Pipeline by Stage of Development, 2013 7 ERYtech Pharma - Monotherapy Products in Pipeline, 2013 8 ERYtech Pharma - Phase III, 2013 9 ERYtech Pharma - Phase II, 2013 10 ERYtech Pharma - Phase I, 2013 11 ERYtech Pharma - Pre-Clinical, 2013 12 ERYtech Pharma - Pipeline By Therapeutic Class, 2013 17 ERYtech Pharma - Pipeline By Route of Administration, 2013 18 ERYtech Pharma - Pipeline Products By Mechanism of Action, 2013 19 ERYtech Pharma - Recent Pipeline Updates, 2013 20 ERYtech Pharma - Dormant Developmental Projects,2013 22 ERYtech Pharma, Other Locations 23
List of Figures
ERYtech Pharma - Pipeline by Indication, 2013 6 ERYtech Pharma - Pipeline by Stage of Development, 2013 7 ERYtech Pharma - Monotherapy Products in Pipeline, 2013 8 ERYtech Pharma - Pipeline By Therapeutic Class, 2013 17